Pemetrexed Plus Bevacizumab in Non Small Cell Lung Cancer

NCT00741221 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Non-small-cell Lung Cancer

Interventions

DRUG: Pemetrexed
DRUG: Bevacizumab

Sponsor

Hellenic Oncology Research Group